Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine for extinction of cue-reactivity in alcohol dependence
NCT00926900Phase 3Unknown
- Sponsor
- Central Institute of Mental Health
- Start
- Mar 2009
- Primary completion
- Apr 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol dependence comparing D-cycloserine with Placebo (2 arms). Primary endpoint: Reduction in cue-reactivity to alcohol-associated stimuli. Status: unknown.
02
Drugs
d-cycloserine
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00926900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00926900.